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Abstract
Sodium nitroprusside (SNP) is widely used in pharmacological studies as a potent vasodilator or a nitric oxide
donor. SNP-induced ataxic effects were assessed in mice by the Joulou-Couvoisier test. Swiss albino mice of both
genders, 2-8 weeks of age, were acclimated at least for 2 weeks to 12 h light (rest span)/12 h dark (activity span).
In 2 and 4 week old mice, maxima of ataxia were found following intraperitoneal administration of a dose ranging
from 3 to 3.6 mg.kg
-1 SNP at ≈ 1 and 13 HALO (Hours After Light Onset). The sublethal toxicity was statistically
dosing-time dependent (c
2 test: P < 0.005). No rhythm was validated in neurotoxicity by cosinor analyses. At the
8
th week of post-natal development (PND), SNP-induced ataxia was greatest at ≈ 1 HALO (69% in males vs. 49% in
females) and lowest at ≈ 13 HALO (21% in males vs. 11% in females) (c
2 test: P < 0.00001). Cosinor analysis also
revealed no statistically significant rhythm in mice injected with 3 or 3.3 mg.kg
-1. However, a significant circadian
(τ = 24 h) rhythm was detected by adjusted cosinor in 3.6 mg.kg
-1-treated mice (P < 0.004). In all studied groups,
SNP-induced motor impairment (expressed in %) was lower during the dark than the light phase. Furthermore,
there was a non-significant gender-related difference in SNP-induced neuronal toxicity with the males more
sensitive than females at every studied PND. The ataxic effects were inversely proportional to the lag time from
injection and to the age of animals (with P < 0.05 only between 2 and 8 week old mice). These data indicate that
both the administration time and age of the animal significantly affect the neurotoxic effects of SNP.
Background
Sodium nitroprusside [Na2(Fe(CN)5NO] has been known
to inorganic chemists since 1849 [1]. SNP is clinically
used for lowering blood pressure in hypertension emer-
gencies [2], for producing controlled hypotension during
anaesthesia [3], and for treating acute myocardial infarc-
tion [4] and chronic heart failure [5]. However, toxic
effects of this drug have been reported [6], originally
ascribed to the nitroso moiety or to various decomposi-
tion products such as cyanide, thiocyanate, and nitrite. It
was postulated that the iron atom of the nitroprusside
complex reacts with free sulfhydryl groups (-SH) in ery-
throcytes and releases cyanide in vivo by nonenzymatic
reaction [7]. Free cyanide can be converted to thiocyanate
b yt h ee n z y m et h i o s u l f a t es u l f urtransferase (rhodanese)
that is present in various tissues [8-10] and particularly
high in liver [11]. Moreover, the vasodilating effect of
SNP is due to of its ability to release nitric oxide (NO)
group to the vascular wall. Release of the NO is triggered
by reduction of the (CN)5FeNO
-2 anion. SNP has been
suggested to cause cytotoxicity through either the release
of cyanide and/or nitric oxide. The major target of NO is
soluble guanylate cyclase [12], but many more molecules
are modified by NO or reactive oxygen species derived
from NO. Other studies reveal that the in vitro cytotoxi-
city of SNP may or may not be mediated by NO [13].
Indeed, some NO donor compounds (e.g. S-nitroso-N-
acetylpenicillamine, S-nitrosoglutathione) have been
shown to protect neurons against oxidative injury and
cell death caused by small molecular weight iron com-
plexes such as ferrous citrate [14]. With this discrepancy,
it is debatable whether the SNP’s neurotoxicity is or is
not due to the NO release.
Biological rhythms are regular and periodic phenomena
existing in all living organisms [15]. In fact, most physio-
logical functions have a rhythm with a period of approxi-
mately 24 h [15]. Desired and nondesired (toxic) effects
of several chemical and physical agents also vary mark-
edly within the 24-h period depending on the time of
administration [16-19]. The rhythms in drug effects are
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any medium, provided the original work is properly cited.suggested not to be due to rhythmic changes in the phar-
macokinetics of drugs but rather to an endogenous
rhythm in drug susceptibility resulting from a circadian
rhythm controlled by an inner clock [20]. Thus, the dos-
ing of medication at the targeted biological time with
reference to circadian rhythms can result in modulation
of its toxicity [21]. The presence of this phenomenon
that is extremely significant for pharmacologic studies
and clinical practice has been demonstrated to a consid-
erable extent in animals [22,23]. The present study inves-
tigated dosing-time-dependent effects of SNP on motor
coordination in 2-, 4-, and 8-week old mice.
Materials and methods
Animals and synchronization
This work was carried out at the Faculty of Sciences of
Bizerte (Tunisia), Laboratory of Toxicometry and Chron-
obiometry. The experiments lasted from February to July,
2006. These were conducted on Swiss albino mice, 2 to 8
weeks of age that were housed 4 or 5 per cage and used
in accordance with the local ethic committee of Tunis
University for use and care of animals in conformity with
the NIH recommendations. Animals were acclimated for
at least 2 weeks prior to and during experiments [24], to
controlled conditions of light cycle (12 h light-12 h dark),
temperature (22 ± 2°C) and relative humidity (50-60%)
with daily checks. Animals were kept in two air-condi-
tioned rooms especially designed for chronobiologic
investigations by having an inverted light regimen to
explore several circadian stages during the usual diurnal
work span. Luminosity was assessed using a Gossen-
Panlux Electronic light meter held at the level of the cage
lid and perpendicular to the incident ray from the light
source. A week after birth, before the assay, young ani-
mals of each gender were distributed randomly and
housed in groups of 5 (4 baby mice with 1 mother
mouse) in cages. All animals were weaned at the age of
21 days. Standard food (ALMES, TN) and water were
provided ad libitum. The desired synchronization was
assessed by the quantification of prominent ultradian
rhythms in 2 week old mice and prominent circadian
rhythms in 4 and 8 week old mice. The study was per-
formed on a total of 324 mice 2-8 aged weeks. Animals
were randomly assigned with respect to age and gender
to six groups (with 6 animals per group), each for treat-
ment with sodium nitroprusside at one of six different
circadian stages denoted as 1, 5, 9, 13, 17, and 21 HALO.
Drug and motor toxicity
Sodium nitroprusside [Na2Fe(CN)5NO.2H2O] brown-red
powder was purchased from E. Merck (Darmstadt, Ger-
many). The SNP is a chemical product of synthesis that
is hydrosoluble but little soluble in alcohol. Solutions
were freshly prepared each experiment day by adding an
adequate volume of sterile distilled water to obtain the
desired concentration. Each dose was administered to
mice in a fixed fluid volume (10 mL.kg
-1 b.w.).
In chronotoxicologic study the use of a high dose
induces the alteration of rhythmicity referring to masking
the dosing-time dependent differences. In adult mice neu-
rotoxic effects of SNP were triggered with doses ranging
from 2.5 to 5 mg.kg
-1-a median toxic dose TD50 (dose
inducing 50% motor inco-ordination) equal to 3.6 ±
0.5 mg.kg
-1. Since there’sal a r g ed i f f e r e n c eo fs e n s i t i v i t y
between 2 and 8 week old mice, only neurotoxic, but non-
lethal, doses were selected for this study. Then, three dif-
ferent doses of SNP were prepared following a geometric
progression with a ratio of 1.1 between each two succes-
sive doses (3.0, 3.3, and 3.6 mg.kg
-1 b.w.). Each mouse of
each age group (6 mice per time point) was administered
intraperitoneally (i.p. )o n c eas i n g l ed o s eo fS N Pa ts i x
pre-selected circadian stages. Behavioural neurotoxicity
(ataxia) has been assessed as motor inco-ordination by
traction test developed by Courvoisier et al. [25]. This sim-
ple test detects neurologic deficits in mice. For this test,
each mouse is hanged from a taut-thread horizontally by
its front paws. In this classical procedure, treated animals
are tested for ten seconds for their ability to wind up one
(or two) hind paw (s) on the thread. The test is considered
positive when the treated animal is able to wind up one
(or two) of its hind paws. Motor performance is measured
as the percentage of animals that fall off the thread or that
can not wind up their paws during the test. SNP was
administrated 5 min before testing. All animals were tested
simultaneously at 5, 10, 15, 20, 25, 30, 35, 40, and 45 min
following injection or until complete recovery. The group
end-point we used for this test was the percentage (%) of
animals falling off the thread or that can not wind up their
paws before 10 seconds elapsed test time. To assess the
precision of the study we repeated four times each experi-
ment with the corresponding dose.
Statistical analysis
Data on all experimental treatment days were expressed
as % of response rate in the corresponding test time.
Means (m) and one standard error of the mean (SEM)
or one standard deviation (SD) were calculated. Time
point data were expressed as m ± SD or ± SEM, and
pertinent curves were drawn. The statistical significance
of differences in motor inco-ordination rate between
groups was substantiated by two-way contingency tables
with generalization of Chi-square test (InStat for MacIn-
tosh GraphPad Software, San Diego, CA, USA). Time
series were analyzed for circadian and other rhythms
using different test periods by the Cosinor method [26].
This method approximates time series data with single
cosine curves of the designated periods within the range
of the dominant suspected frequencies. Thus, for each
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rhythm, the hypothesis of non-null amplitude with the
corresponding P value. The best fitting (least-square
method) cosine function approximating the time-series
data provides parameters to characterize a rhythm,
namely the mesor (M: 24 h adjusted mean), amplitude
(A: half of the difference between the peak and trough
of the best fitted cosine function), and acrophase (F:
peak time location, with light onset 0 HALO used as
phase reference). All rhythm characteristics were
obtained with their 95% confidence limits when a
rhythm was detected. This was achieved when A dif-
fered from zero (non-null amplitude F test) with P ≤
0.05. The period that corresponded to the highest
amplitude (highest percentage rhythm, i.e., accounting
for the greatest variance) and the lowest residual mean
square (error) was considered the dominant period if
P ≤ 0.01. If the confidence limits of the acrophase for a
given trial period (e.g., τ = 24 h, 12 h) are greater than
± 2 h, quantification of the acrophase and amplitude is
questionable [27] because the waveform pattern of the
time series is likely to deviate from a sinusoidal pattern
[28]. Therefore, the significance of both conventional
and chronobiologic statistics was required to validate
the temporal changes as rhythms [29]. Since we conduct
multiple tests (of non-null hypotheses) it is necessary to
use a multiple testing correction to address the problem
of the critical significance level (P-value cutoff). One of
simplest and conservative approaches used is Bonferroni
correction. This method allows adjusting of P-values
derived from multiple statistical tests to correct for
occurrence of false positives. For this method, the P-
value of each test (provided by cosinor) is multiplied by
the number of performed tests (n = 36, in this case). If
the corrected P-value is still below the error rate, the
test will be significant: Corrected P-value = P-value ×
36 < 0.05.
Results
In 2 week old mice, sodium nitroprusside-induced loco-
motor impairment (ataxia) was least at 9 HALO, affect-
ing only 30% of the animals, and was greatest at 1 and
13 HALO, affecting 62% and 56% of the animals (c
2 =
16.51, P < 0.005), respectively (Figure 1). Similarly, in
the young-weaned (4 week old) mice, drug dosing at 1
and 13 HALO resulted in highest ataxia (Figure 2).
Ataxia rate differed as a function of SNP dosing-time,
the difference being validated by c
2 test (P <0 . 0 0 5 ) .I n
both genders, no statistically significant rhythm was
detected by Cosinor analyses (Tables 1 and 2). With the
three used doses (3.0, 3.3, and 3.6 mg.kg
-1), the ataxic
effects were higher in males than in females but not sta-
tistically significant. The gender-related difference in
ataxia rates persisted until age 8 weeks, but their
Figure 1 Variations of ataxia according to the dosing time of
sodium nitroprusside in two-week old male and female mice.
The three panels refer to three doses: 3 (a), 3.3 (b) and 3.6 mg.kg
-1
(c). Values are the mean ± SEM of four independent experiments.
The black bar corresponds to the dark period. Maximums of motor
incoordination correspond, irrespective to the gender and dose, to
drug dosing at 1 and 13 HALO. c
2 test validated a statistically
significant difference according to dosing-time in both genders (P <
0.006). No statistically significant rhythm was detected by Cosinor
analysis with correction for multiple testing.
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age 2 weeks. Moreover, with the exception of the 4
week old male mice (P ≤ 0.01: c
2 test between doses 3.0
and 3.6 mg.kg
-1), there was no statistically significant
dose-dependent ataxia at any postnatal development
(PND) stage. Chronograms of ataxia at age 8 week
(Figure 3) show curve patterns with the peak time
located at ≈ 1 HALO (69% in males vs. 49% in females)
and the trough time at ≈ 13 HALO (21% in males vs.
11% in females) (P < 0.00001: c
2 test). No statically
significant rhythm was detected in 3 and 3.3 mg.kg
-1-
treated 8 week old mice. However, a significant 24 h
rhythm was detected by Cosinor analysis in mice treated
with 3.6 mg.kg
-1 (P < 0.004). The behavioural neurotoxi-
city was inversely proportional to the age of animals;
with significant (P < 0.05) difference only between 2 and
8 week old mice.
Discussion
Although toxic effects of SNP in mice are well estab-
lished, time-of-day oscillations in SNP tolerance have
not been reported. Our results clearly indicate that
motor activity varies as a function of the time of day
after administration of SNP in mice.
Analysis of the data by means (of percent motor inco-
ordination) of c
2 test revealed significant (P < 0.005) var-
iations of neuronal toxicity according to dosing-time of
S N Pi np r e - w e a n e d( 2w e e ko l d )a n dy o u n g - w e a n e d( 4
week old) mice. Across of doses, mice treated during the
second-half of daily sleep/activity phases (9, 21 HALO)
showed lower motor inco-ordination, whereas mice trea-
ted during the early of sleep/activity spans (1, 13 HALO)
showed much higher neurologic effects. Modulation of
S N Pn e u r o n a lt o x i c i t yb yc o s i n o rm e t h o dr e v e a l e dn o
significant ultradian (12 h) or circadian (24 h) rhythms,
suggesting that the experimental distribution differed
from a sinusoidal pattern. Raw data (Figures 1 and 2)
confirm this; the curve patterns differ from regular cosine
functions and it helps to explain why the cosinor pro-
vided acrophases and amplitudes with rather large confi-
dence limits.
T h et w o - w a yc o n t i n g e n c yt a b les revealed significant
(P < 0.00001) time-of-day variability differences within
24-h time scale for all tested doses in young-grow-up
(8 week old) animals. The most statistically significant
circadian time-dependent toxicity was seen at 3.6 mg.kg
-
1-dose of SNP, where ~70% of the mice reacted nega-
tively when treated just after light onset (1 HALO). This
is contrasted with a lower neurotoxicity when mice
r e c e i v e dt h es a m ed o s eo fS N Pd u r i n gt h eb e g i n n i n go f
the activity span (13 HALO). Cosinor analysis revealed a
significant circadian rhythm only in 3.6 mg.kg
-1-treated
mice. The maximum of SNP toxicity was at 1 HALO
with regard to the raw data depicted in the chronograms
Figure 2 Variations of ataxia according to the dosing time of
sodium nitroprusside in four-week old male and female mice.
The three panels refer to three doses: 3 (a), 3.3 (b) and 3.6 mg.kg
-1
(c). Values are the mean ± SEM of four independent experiments.
The black bar corresponds to the dark period. Maximums of motor
incoordination correspond, irrespective to the gender and dose, to
drug dosing at 1 and 13 HALO. c
2 test validated a statistically
significant difference according to dosing-time in both genders (P <
0.0004). No statistically significant rhythm was detected by Cosinor
analysis with correction for multiple testing.
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determined acrophase. However, although SNP neuro-
toxicity exhibits a marked time-of-day dependence in 3
and 3.3 mg.kg
-1-treated mice cosinor analysis validated
no statistically significant circadian variation, indicating
that the temporal patterns of drug effects are somewhat
non sinusoidal. In this study, the amplitude of the 24-h
SNP neurotoxicity rhythm (Table 3) was greater with the
highest dose of SNP (3.6 mg.kg
-1), implying that a greater
proportion of the variability in tolerance was attributable
to time-of-day dependent differences. These results sug-
gested that the waveform of drug effects might be
depending on, among other things, both dose and age of
animal. The absence of rhythmicity of neurotoxic effects
in pre-weaned and young-weaned mice could be
explained by the immature physiological functions of
some organs, as the central nervous system is still not
fully developed during the first period of post-natal life
[30]. Also, it has been suggested that the circadian system
of foetuses and newborn pupsi se n t r a i n e dm o s t l yb y
nonphotic maternal cues during prenatal and early post-
natal development [31]. Indeed, the detection of signifi-
cant circadian rhythms later in 8 week old mice injected
with dose 3.6 mg.kg
-1 would be related in part to the
development of many aspects of peripheral as well as
central nervous system functioning. It has been demon-
strated that amplitude of the circadian component of sev-
eral rhythms increases with growth and development of
Table 1 Parameters of ultradian and circadian rhythms of sodium nitroprusside-induced motor incoordination in
2 week old mice
Dose (mg/kg) Gender Period
τ (h)
Mesor ± SEM
(% of ataxia)
Amplitude ± SD
(% of ataxia)
Acrophase
±SD (min)
b
Adjusted P
a
Male 12 50 ± 4 17 ± 15 1.2 ± 120 NS
3.0 24 51 ± 4 10 9.7 NS
Female 12 34 ± 5 19 ± 18 2.1 ± 120 NS
24 35 ± 5 2 21.2 NS
12 49 ± 5 26 ± 17 1.9 ± 74 NS
3.3 Male 24 50 ± 5 16 4.8 NS
12 45 ± 4 15 ± 14 2.3 ± 120 NS
Female 24 45 ± 4 6 1.3 NS
12 45 ± 4 16 ± 14 2.3 ± 144 NS
3.6 24 55 ± 4 16 ± 14 2.3 ± 240 NS
Male 12 37 ± 5 19 ± 18 1.9 ± 120 NS
Female 24 38 ± 5 2 12.5 NS
a From an F test of the rejection of the null amplitude hypothesis.
b Time of maximum in fitted cosine function, in HALO.
NS: Not significant
Table 2 Parameters of ultradian and circadian rhythms of sodium nitroprusside-induced motor incoordination in
4 week old mice
Dose
(mg/kg)
Gender Period
τ (h)
Mesor ± SEM
(% of ataxia)
Amplitude ± SD
(% of ataxia)
Acrophase
±SD (min)
b
Adjusted P
a
Male 12 30 ± 4 15 ± 14 1.1 ± 120 NS
3.0 24 28 ± 4 2 5.4 NS
Female 12 33 ± 4 15 ± 14 1.2 ± 120 NS
24 33 ± 4 12 3.2 NS
12 49 ± 5 26 ± 17 1.9 ± 74 NS
3.3 Male 24 40 ± 4 10 8.8 NS
12 31 ± 5 17 ± 16 1.4 ± 120 NS
Female 24 32 ± 5 2 1.5 NS
12 65 ± 4 18 ± 13 1.2 ± 90 NS
3.6 24 64 ± 4 16 ± 13 4.5 ± 228 NS
Male 12 36 ± 5 16 ± 15 2.0 ± 120 NS
Female 24 34 ± 3 4 5.0 NS
a From an F test of the rejection of the null amplitude hypothesis.
b Time of maximum in fitted cosine function, in HALO.
NS: Not significant
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showed a dose-dependent high toxicity of SNP at any
PND stage in male mice comparatively to females.
Indeed, it has been shown that male mice are highly sen-
sitive to cyanide as compared to females [33].
Our studies therefore clearly show that mice exhibit
time-of-day dependence in SNP tolerance, which is prob-
ably due to endogenous and/or exogenous periodic fac-
tors. Furthermore, temporal pattern of SNP neurotoxicity
depends upon the age of animal for the same dose.
Although there are many reports on the changes in the
pharmacokinetic of some drugs depending on the time of
administration, there is not enough information to deter-
mine whether a circadian variation is present in the
pharmacokinetics. However, in animal experiments, time-
dependent oscillations are observed in enzyme activities
for drug metabolism in the liver [34-36]. But then, in addi-
tion, it is necessary to demonstrate a reasonable relation
between the waveforms of the temporal patterns of drug
levels and their effects. In our previous studies, daily varia-
tions of rhodanese, a principal enzyme of cyanide (consid-
ered as responsible of SNP toxicity) detoxification, were
observed in various tissues, including the liver [9-11].
However, there was no correlation between SNP-induced
neurotoxicity and the temporal variations of enzyme activ-
ities, suggesting that the toxicity of SNP is not only
mediated by cyanide, and/or that the enzyme rhodanese is
not the only one playing a role in cyanide detoxification. It
has been reported that even the NO that is released by
SNP induces neuronal toxicity [37]. That toxicity might be
related to the SNP-induced oxidative effects, suggesting
the involvement of reactive oxygen species (ROS) in this
neurotoxicity. Indeed, Fukushina et al. [37] have demon-
strated that SNP-induced neurotoxicity is attenuated by
super-oxide dismutase (SOD), an enzyme well known to
scavenge superoxide radicals (O2
●-). However, the partial
protective effect of SOD is likely due to the fact that fac-
tors other than ROS may also be involved in SNP-induced
neurotoxicity. Moreover, in addition to SOD, several other
anti-oxidant factors such as reduced glutathione, glu-
tathione peroxidase, and catalase may contribute to the
reduction of the increased ROSp r o d u c t i o n[ 3 8 , 3 9 ] .T h e
circadian peak and trough times of ataxia in 8 week old
animals matched well with the observed maximum and
minimum of oxidative effects after SNP (2.5 mg.kg
-1)
injection at the early light and dark spans, respectively
[39]. However, the high sensitivity of male mice compared
to females matched the observed high levels of rhodanese
in females [9-11], indicating partially the great influence of
cyanide on SNP-induced toxicity. On the other hand,
these results revealed that there were opposite effects
depending on the time of administration in SNP-induced
neurotoxicity, illustrating that there are not only quantita-
tive differences in drug effects.
Figure 3 Variations of ataxia according to the dosing time of
sodium nitroprusside in eight-week old male and female mice.
The three panels refer to three doses: 3 (a), 3.3 (b) and 3.6 mg.kg
-1
(c). Values are the mean ± SEM of four independent experiments.
The black bar corresponds to the dark period. Maximum and
minimum of motor incoordination correspond, irrespective to the
gender and dose, to drug dosing at 1 and 13 HALO, respectively. A
dosing time-related effect was statistically validated by c
2 test (P <
0.00005) in both genders. Circadian (τ = 24 h) rhythms were
confirmed by Cosinor analysis with correction for multiple testing
only in mice treated with 3.6 mg.kg
-1 (P < 0.05).
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essentially similar regardless of the time-day of administra-
tion. These analyses indicate that the safest time for
SNP may be the second half of the daily activity span, a
time comparable to 1 pm to 7 pm for nocturnally resting
human beings. However, despite the appearance of restless
behaviour and ataxia at all the studied PND stages, circa-
dian rhythms were only detected at the dose 3.6 mg.kg
-1
in young-grown-up mice. This phenomenon has been stu-
died for other drugs in many animal species. These varia-
tions seem to be considered endogenous resulting from
the daily variation in drug susceptibility of the target cells,
which is not dependent on drug pharmacokinetics. When
considering the assessed parameter in this study, the tem-
poral variation might be probably attributed to the
rhythms in the neurotransmitters, receptors, and second
messengers.
In conclusion, these results indicate that there are
time-dependent variations in SNP-induced neurotoxi-
city. The neurotoxic effect of SNP has been attributed
to its production of ROS by releasing NO. However,
no experimental evidence to support this interesting
hypothesis is yet available. One potentially useful way
of demonstrating oxidative effects (NO neurotoxicity)
from SNP might be the administration of sodium thio-
sulfate (which may act by converting CN to thiocyante
with assistance of the enzyme rhodanese) prior to the
administration of SNP and the measure of ROS
generation.
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